BV, Yeast, and the Vaginal Microbiome: Everything you need to know

There has been information circulating as long as most of us remember surrounding basic things like yeast infections and overall vaginal health, and there is increasingly more information on social media these days on the vaginal microbiome. We were told certain soaps can help keep your vagina “clean” and even to eat certain foods for our vaginal health. There are dozens of recommended supplements, suppositories, and even testing kits you can order online to identify hundreds of different species of bacteria in your vaginal flora… but why does all of this matter and what do we really need to do for our vaginal health? 

The Vaginal Microbiome, Who is She

The vaginal microbiome, similar to the gut microbiome, has been more recently found to have an important role in a woman’s health. When you search “vaginal microbiome” in the pubmed database, in 2009 there were 33 studies published, and in 2025 there were 784! This shows the increasing understanding of its significance. 

Our body contains various “healthy bacteria” at all times. These bacteria naturally occupy our skin, mouth, gut, genital, and rectal areas. Studies show our vaginal microbiome consists of billions of microbes.1 As we all learned in ninth grade biology, there are different relationships within ecosystems, there is commensalism, mutualistic, parasitic, etc. The bacteria in the vagina and their human host luckily form a mutualistic relationship. The host provides a warm, nutritious environment while the bacteria provide antiinflammatory and antimicrobial benefits.1 The host’s environment is cultivated based on a variety of factors, with internal factors including hormone levels, age, and immunity, and external factors including antibiotic use, infections, and environmental exposures.1 If one of these factors is off, the entire microbiome can be altered and predispose a woman to infections. In the vagina, the predominant bacterial family is the Lactobacillus species. This group secretes various antimicrobial chemicals that keep the bad bacteria at bay when your vagina is exposed to outside pathogens from sexual activity, period blood, exposure to water or new soaps, chronic stress, etc. There are over 200 different Lactobacillus species, with L. crispatus often the most predominant species providing helpful antimicrobials like lactic acid and hydrogen peroxide. Other species include L.gasseri, L.jensennii, L. rhamnosus, and L.iners. Lactobacillus species are beneficial microbiota in the vagina and are commonly found in vaginal probiotic pills or suppositories. L.iners is often found in healthy women, however if it is dominant it may indicate a higher likelihood of dysbiosis or bacterial vaginosis infection.1 There is a balance of these bacteria in healthy women, which can be derailed from menstruation, sexual activity, pregnancy, or infection. The vaginal microbiome can be an important indicator of a healthy women. Interestingly, the vaginal microbiome of the mother plays an essential role in the initial bacterial colonization of newborn infants and development of healthy skin and gut flora. Sometimes, OB/GYNs will even colonize some of the vaginal fluid onto fetuses born via cesarean section, a process called “vaginal seeding.” 

Let’s discuss some of the common infections that occur when the vaginal microbiome is offset:

Bacterial Vaginosis

BV is a highly prevalent disorder of the vaginal microbiota among women of reproductive age worldwide.1 While BV is generally a low risk infection that affects many women worldwide, it is also associated with adverse gynecologic and obstetric outcomes, such as sexually transmitted infections, pelvic inflammatory disease, and preterm birth.1 It affects up to 30% of women worldwide with almost $5 billion spent on treatment annually.2 

The predominant pathogen associated with BV is the bacteria Gardnerella vaginalis, but it can be caused by several bacteria. Other reported bacterial species include Prevotella, Atopobium, Mobiluncus,and  Bifidobacterium.1  It presents with symptoms of thin white or sometimes grey discharge, and a notorious fishy odor, sometimes more noticeable after sexual intercourse. Infection with BV may also cause pain with sex, vaginal itching, or burning with urination. However, sometimes you may not notice any symptoms. While BV is not technically termed a “sexually transmitted infection (STI)” it is most common in women that are sexually active. However, emerging data reveals BV can be transmitted sexually.

Your healthcare provider will diagnose the condition with a vaginal or cervical swab. They may perform a KOH prep or “wet prep” where they will look at the discharge under the microscope, looking for “clue cells,” characteristic of Gardnerella vaginalis. Alternatively, they may send off the tube for a PCR test that takes a couple hours to days.

Treating Bacterial Vaginosis

Standard BV treatment requires a prescription from a healthcare provider for metronidazole, either given orally in pill form or through a vaginal gel. The oral medication is generally prescribed to be taken twice a day for 7 days. It can occasionally be tough on the stomach, causing GI upset or diarrhea. Other side effects include a metallic taste in the mouth and a disulfiram-like reaction when combined with alcohol. This is due to the metabolization of both the medication and alcohol, leading to terrible symptoms of stomach upset, nausea, or vomiting if alcohol is consumed during treatment or up to 3 days following the last dose. The vaginal gel is used nightly for 5 days, and often has no systemic side effects but occasionally vaginal irritation, vaginal yeast infection, headache, nausea, stomach upset. Both options are considered safe in pregnancy and lactation at the lower doses with longer duration, with weak and inconsistent data on low risks of birth defects or pregnancy complications. The oral metronidazole medication has a possible risk of causing infant diarrhea or thrush (candida infection in the mouth). 

Alternatively, BV can be treated with clindamycin vaginal cream. The cream is inserted intravaginally for 7 days. Similarly to the metronidazole gel, it can predispose users to yeast infection or vaginal irritation. This treatment is also safe for pregnancy and breastfeeding.  Clindamycin is found to be just as effective as metronidazole, as it is also a first line treatment. It is also more effective against one of the bacteria involved in BV infections, Atopobium vaginae (now Fannyhessea vaginae), than metronidazole. However, interestingly, metronidazole has been shown to maintain slightly higher clinical cure rates 1 month after treatment and is better at restoring normal vaginal pH and healthy microbiome.3

Boric acid is a suppository that can be purchased over the counter at most pharmacies and grocery stores. It can be used as a way to prevent BV, with suggestions of use once following sex or for 2-3 days following your menstrual period. Alternatively, it can be used daily for a couple weeks in conjunction with standard treatment to prevent eruption of another infection and disrupt the biofilm created by BV, which can be a tool in persistent BV or recurrent BV cases.4 It has not been completely studied as a monotherapy for BV compared to traditional first line agents, however one study showed 7 days of suppository use showed it has moderate ability to treat BV, but lower efficacy compared to metronidazole or clindamycin.5 Similarly, it has been used in refractory yeast infection cases, with 14 days of use following standard treatment.6 Boric acid should NOT be taken orally and is not advised for use during pregnancy. In summary, a randomized control trial is needed to determine if it can be used as standard of care in treating bacterial vaginosis.

Can Men get BV and what is the role of partner treatment?

As we discussed above, bacterial vaginosis is primarily associated with sexually active women. Since it takes two to tango, isn’t it possible men have it too? Well, not exactly. Men can carry BV-related bacteria on the skin of their penis, around the coronal sulcus and in the urethra or urinary tract. Research has shown that the microbiome of a male partner’s penis becomes more similar to the female partner’s vaginal microbiome with time. Kinda cool! However, in women with frequent BV infections, it is thought the male partner may be continually reinfecting the female. A recent study by the New England Journal of Medicine called the StepUp trial studied women with BV and split them into two groups: one to receive standard treatment of metronidazole and the second group to receive metronidazole along with their partner treated with a combination of metronidazole orally and clindamycin cream applied to the penis for 7 days. The trial was actually stopped early because the group that included partner treatment had a significantly lower rate of recurrence after 1 and 3 months than the female-treatment-only group.7 If you’ve had more than one infection with BV in the last few months, ask your healthcare provider about partner treatment.

Vaginal Probiotics

There is emerging data regarding vaginal probiotics, both oral and vaginal suppositories. However, there is not robust enough data yet to formally recommend them. Small studies are encouraging in regards to BV prevention, in conjunction with traditional BV treatment, or restoration of the healthy vaginal microbiome following treatment.7-9 The thought is that if we replace the healthy vaginal bacteria, the rates of BV infection reduce. Oral and vaginal probiotic use following BV treatment appears to increase short term cure rates but long term cure rates are mixed.9 There is no clear superior route between oral and vaginal suppositories, with oral probiotics often recommended daily intake and vaginal suppositories are for short term use. The Lactobacillus species included in each probiotic varies from company to company, with L.crispatus, L. rhamnosus, L.gasseri, and L. jensenii being the most prominent types. L.crispatus, as discussed above, is the most studied and efficacious species, and the one to look for on the back of the bottle.10-11 You can find our recommended probiotics at our supplement page here.

Vulvovaginal Candidiasis (Yeast infection)

Everyone has heard of a yeast infection before, and most women have experienced one. They are notorious for sprouting after taking an antibiotic, staying in swimsuits or sweaty clothes for long periods, or when a person uses a new soap in the vaginal area. Essentially, when the gut and/or vaginal microbiome are thrown off, the body is predisposed to yeast overgrowth. Scented wipes, soaps, lotions, or even condoms and/or lubricants can also irritate the vaginal microbiome, giving way for this fungal infection to take over. Yeast infections are fungal infections caused by the Candida species, most commonly Candida albicans. This organism can lead to infections virtually everywhere in the body, such as the mouth (known as thrush), esophagus, skin, urinary tract, and rarely the blood. Vaginal candidiasis leads to symptoms of thick, white discharge (sometimes described as “cottage cheese-like,” however I refrain from this description as many of us are on the cottage cheese train…) and causes vaginal itching and/or burning sensations. The infection can be incredibly uncomfortable until it is treated. However, the good news is they are often treatable.

Treating a Yeast Infection

Standard treatment for yeast infection is with fluconazole, brand name diflucan. One dose often does the trick, but a medical provider may give you 2-3 tablets especially if you’ve had recurrent infections or continue to have symptoms after one dose. Over the counter treatments for yeast infection are generally adequate to resolve a yeast infection, usually the medication options include miconazole (brand name Monistat), clotrimazole, or tioconazole. They may be offered as 1, 3, or 7 day dosing options. A steroid-based cream may also be included in the treatment regimen to apply on the vulva for itching and irritation. 

As stated above, boric acid can be used in cases of yeast infections that do not respond to fluconazole, however this is not yet recommended as standard of care. 

Chlamydia, Gonorrhea, and Chlamydia

These are sexually transmitted infections (STIs) and the infections your provider will test for if you request STI testing. If you are in early pregnancy, most providers will test for these infections to ensure you get treated as soon as possible as they can cause pregnancy and fetal complications. In addition, they will test for HIV, Hepatitis B and C, and Syphilis in the blood. Chlamydia trachomatis and Neisseria gonorrheae are bacterial infections, and are very commonly transmitted through unprotected sex. They can lead to pelvic inflammatory disease if untreated, which promotes scarring in the uterus and fallopian tubes, potentially leading to infertility. Trichomoniasis is a parasitic infection caused by Trichomonas vaginalis, often causing abnormal discharge. These infections are treated with antibiotics and it is imperative the partner is treated as well.

Ureaplasma

Ureaplasma species (U. urealyticum and U.parvum) are common vaginal commensal organisms found in 40-80% of sexually active women.12 It is not associated with vaginitis, abnormal vaginal discharge, bacterial vaginosis or yeast infections. While ureaplasma parvum presence can be more associated with BV, it is not a causal agent or pathologic organism.12 Many healthy women are colonized with ureaplasma without symptoms. However, there is emerging data that it may contribute to both male and female infertility and early pregnancy loss or preterm birth.21-22 It is not yet recommended to screen asymptomatic, healthy women since it can be a commensal organism and also not yet recommended to routinely test or treat pregnant women.23 If you have a history of infertility or pregnancy loss, ask your provider about ureaplasma testing and treatment.

Mycoplasma

Mycoplasma is a bacterial species that has more association with pathology and infection. The common genital organisms are Mycoplasma genitalum, Mycoplasma hominis, and Mycoplasma girerdii. 

Mycoplasma genitalum is a sexually transmitted bacteria. It is detected more frequently among women with BV and is also more strongly linked to cervicitis (infection of the cervix) and pelvic inflammatory disease (PID).14 It is also not yet recommended to screen for it in asymptomatic individuals. Treatment is reserved for men with nongonococcal urethritis and women with persistent cervicitis. The treatment is doxycycline and azithromycin for both you and your partner. 

Mycoplasma hominis is a commensal bacteria that is often present in healthy women. However, it is most associated with bacterial vaginosis. It was found to be present in 60% of women with BV in one study.15 This doesn’t mean it causes BV, but when levels of Gardnerella vaginalis or Prevotella are higher, levels of M.hominis are likely to be high too. It is associated with abnormal vaginal discharge, pelvic inflammatory disease, miscarriage, stillbirth, female infertility, and postpartum endometritis.16,21-22 Typically  treating the bacterial vaginosis infection will reduce the presence of mycoplasma, and routine screening even in cases of recurrent bacterial vaginosis is not recommended. However, some providers may treat the infection if you have infertility or recurrent pregnancy loss, recurrent BV, or symptoms of pelvic inflammatory disease.22 It is treated with doxycycline. 

Mycoplasma girerdii is a bacteria almost exclusively found in women with Trichomonas, a sexually transmitted infection by a parasite. It is not routinely tested for and there is no specific antibiotic regimen.

Vaginal Care

I (Kate) see these infections all the time in the clinic, and the amount of times I hear patients use a new soap in the vagina or some other “pH balancing” product is astounding. There is some great marketing out there, but these products are often not your friends. They disrupt the natural, healthy lactobacillus species and give way to other infections to take over. If I could make a public service announcement for all women, it may be to not use vaginal soaps! In general, allowing warm water to run down your body and around the vulva is sufficient, as I mentioned above, your vagina is a self capable organ and does not need you to step in for its cleansing process. 

You may have heard that eating certain citrus fruits may help with your vaginal scent or health, yet there is no established evidence of this. However, eating probiotic rich foods such as yogurt, kefir, sourdough bread, aged cheese, cottage cheese, pickles, sauerkraut, and others can certainly be beneficial for both your gut and vaginal microbiota. Studies also show that eating more plants and fiber can reduce the risk of bacterial vaginosis infection, likely because of their contribution toward a healthy microbiome.18 

What about at home vaginal microbiome testing?

There are many new companies and marketing campaigns advertising at home testing of your vaginal microbiome. The targeted audience is typically women with recurrent infections or with infertility, understandably. As of right now, the stance from clinical experts is that there is no proven benefit for microbiome testing improving fertility outcomes or recurrent infections. The reason for this is there is no standardized outcomes or proven treatment for the dysbiosis that may be detected by the test. As previously mentioned, the data surrounding vaginal probiotics is lacking strength, and antibiotics are not shown to play a significant role in restoring the healthy bacteria. In the clinical world, the IVF space is generally the only setting where vaginal microbiome testing is being utilized. Although, we do have strong data that women with lactobacillus-dominated vaginal microbiota have higher rates of conception and higher IVF rates.19 Therefore, if you have the financial means (as these tests are usually hundreds of dollars) and are struggling in either of these areas, its a tool you can look into for more information on your health, but may not have an actionable impact on your fertility or vaginal health journey.

Take Home Points
  • The vaginal microbiome is a complex community dominated by Lactobacillus species and is unique to each women
  • BV and yeast infections are common infections of the genital region, but are abnormal and should not be recurrent. Seek medical advice if you have recurrent infections
  • Ureaplasma and mycoplasma are common bacteria that often naturally reside in the vagina; however the presence of mycoplasma may indicate bacterial vaginosis infection or cause a painful infection in the cervix
  • Avoid the marketing of vaginal soaps, “pH balance,” etc. Keep vaginal care simple
  • If you are prone to BV or yeast infections, visit an OB/GYN clinic, ask about partner treatment, and think about trying vaginal probiotics or boric acid 
  • If you are trying to conceive, you may consider getting tested for sexually transmitted infections chlamydia, gonorrhea, trichomoniasis, and possibly mycoplasma and BV if you have abnormal discharge, painful sex, or recurrent infections
  • At home vaginal microbiome testing is not recommended because there is no proven treatment for an inadequate vaginal microbiome, and it has not been shown to increase conception or live birth rates

Best,


The PA Sisters

Disclaimer: this is not medical advice, but for informational and educational purposes only. Please consult your medical provider for unique medical guidance tailored to you. 

References
  1. Chen X, Lu Y, Chen T, Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021 Apr 7;11:631972. doi: 10.3389/fcimb.2021.631972. PMID: 33898328; PMCID: PMC8058480.
  2. Peebles K.,Velloza J., Balkus J. E., McClelland R. S., Barnabas R. V. (2019). High global burden and costs of bacterial vaginosis: a systematic review and meta-Analysis. Sex Transm. Dis.46, 304–311. doi: 10.1097/OLQ.0000000000000972
  3. Metronidazole. Food and Drug Administration. Updated date: 2023-01-30.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80c79325-1ea4-46f8-b9b8-967b7640c51d 
  4. Reichman O, Akins R, Sobel JD. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Transm Dis. 2009 Nov;36(11):732-4. doi: 10.1097/OLQ.0b013e3181b08456. PMID: 19704395.
  5. Marrazzo JM, Dombrowski JC, Wierzbicki MR, Perlowski C, Pontius A, Dithmer D, Schwebke J. Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial. Clin Infect Dis. 2019 Feb 15;68(5):803-809. doi: 10.1093/cid/ciy554. PMID: 30184181; PMCID: PMC6376090.
  6. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16. PMID: 26679628; PMCID: PMC4725385.
  7. Vodstrcil LA, Plummer EL, Fairley CK, Hocking JS, Law MG, Petoumenos K, Bateson D, Murray GL, Donovan B, Chow EPF, Chen MY, Kaldor J, Bradshaw CS; StepUp Team. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med. 2025 Mar 6;392(10):947-957. doi: 10.1056/NEJMoa2405404. PMID: 40043236.
  8. Li C, Wang T, Li Y, Zhang T, Wang Q, He J, Wang L, Li L, Yang N, Fang Y. Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials. Eur J Pharmacol. 2019 Dec 1;864:172660. doi: 10.1016/j.ejphar.2019.172660. Epub 2019 Sep 25. PMID: 31562865.
  9. Zhang R, Liu Z, Zhang Y, Mi L, Zhang D, Li Y, Liao Q. Probiotics reduce the recurrence of asymptomatic bacterial vaginosis in Chinese women. Sci Rep. 2025 Mar 20;15(1):9689. doi: 10.1038/s41598-025-92843-7. PMID: 40113887; PMCID: PMC11926242.
  10. Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, Fang F. Probiotics for vulvovaginal candidiasis in non‐pregnant women. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No.: CD010496. DOI: 10.1002/14651858.CD010496.pub2. Accessed 20 July 2026.
  11. Happel AU, Kullin B, Gamieldien H, Wentzel N, Zauchenberger CZ, Jaspan HB, Dabee S, Barnabas SL, Jaumdally SZ, Dietrich J, Gray G, Bekker LG, Froissart R, Passmore JS. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis. PLoS Pathog. 2020 Jun 4;16(6):e1008559. doi: 10.1371/journal.ppat.1008559. PMID: 32497109; PMCID: PMC7271994.
  12. Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T. P., Hemmerling, A., & the Lactin-V Trial Team. (2020). Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis. New England Journal of Medicine, 382(20), 1906–1915. https://doi.org/10.1056/NEJMoa1915254
  13. Plummer EL, Vodstrcil LA, Bodiyabadu K, Murray GL, Doyle M, Latimer RL, Fairley CK, Payne M, Chow EPF, Garland SM, Bradshaw CS. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum Associated With Specific Genital Symptoms and Clinical Signs in Nonpregnant Women? Clin Infect Dis. 2021 Aug 16;73(4):659-668. doi: 10.1093/cid/ciab061. PMID: 33502501.
  14. Rumyantseva T, Khayrullina G, Guschin A, Donders G. Prevalence of Ureaplasma spp. and Mycoplasma hominis in healthy women and patients with flora alterations. Diagn Microbiol Infect Dis. 2019 Mar;93(3):227-231. doi: 10.1016/j.diagmicrobio.2018.10.001. Epub 2018 Oct 4. PMID: 30344067.
  15. Schwebke JR, Nyirjesy P, Dsouza M, Getman D. Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing. J Clin Microbiol. 2024 Sep 11;62(9):e0081624. doi: 10.1128/jcm.00816-24. Epub 2024 Aug 14. PMID: 39140739; PMCID: PMC11389145.
  16. Cox C, Watt AP, McKenna JP, Coyle PV. Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):481-7. doi: 10.1007/s10096-015-2564-x. Epub 2016 Jan 21. PMID: 26796553.
  17. Ma C, Du J, Dou Y, Chen R, Li Y, Zhao L, Liu H, Zhang K. The Associations of Genital Mycoplasmas with Female Infertility and Adverse Pregnancy Outcomes: a Systematic Review and Meta-analysis. Reprod Sci. 2021 Nov;28(11):3013-3031. doi: 10.1007/s43032-020-00399-w. Epub 2021 Jan 4. PMID: 33398853.
  18. Shivakoti R, Tuddenham S, Caulfield LE, Murphy C, Robinson C, Ravel J, Ghanem KG, Brotman RM. Dietary macronutrient intake and molecular-bacterial vaginosis: Role of fiber. Clin Nutr. 2020 Oct;39(10):3066-3071. doi: 10.1016/j.clnu.2020.01.011. Epub 2020 Jan 29. PMID: 32033845; PMCID: PMC7387193.
  19. Du B, Yang Y, He L, Tang Y. Microbiota and infertility: a translational review of mechanisms and clinical applications in assisted reproduction. Eur J Obstet Gynecol Reprod Biol. 2026 Feb 20;318:114941. doi: 10.1016/j.ejogrb.2026.114941. Epub 2026 Jan 5. PMID: 41518932.
  20. Cheng C, Chen X, Song Y, Wang S, Pan Y, Niu S, Wang R, Liu L, Liu X. Genital mycoplasma infection: a systematic review and meta-analysis. Reprod Health. 2023 Sep 12;20(1):136. doi: 10.1186/s12978-023-01684-y. PMID: 37700294; PMCID: PMC10496402.
  21. Lee JS, Kim KT, Lee HS, Yang KM, Seo JT, Choe JH. Concordance of Ureaplasma urealyticum and Mycoplasma hominis in infertile couples: impact on semen parameters. Urology. 2013 Jun;81(6):1219-24. doi: 10.1016/j.urology.2013.02.044. Epub 2013 Apr 18. PMID: 23602797.
  22. Bishop S, Truong A, Jaslow C, Kutteh W. Recurrent pregnancy loss and the role of Mycoplasma and Ureaplasma: a prospective cohort study with outcome after treatment. Fertil Steril. 2026 May;125(5):852-859. doi: 10.1016/j.fertnstert.2025.12.015. Epub 2025 Dec 22. PMID: 41443367.
  23. Raynes‐Greenow CH, Roberts CL, Bell JC, Peat B, Gilbert GL, Parker S. Antibiotics for ureaplasma in the vagina in pregnancy. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD003767. DOI: 10.1002/14651858.CD003767.pub3. Accessed 27 July 2026.

Leave a Reply

We are The PA Sisters

Welcome to our blog site! We hope through our blog that we can provide evidence-based information for you to feel more knowledgeable and empowered about your health.

Let’s connect